MedPath

TARO-TADALAFIL

TARO-TADALAFIL

Approved
DIN Number

02452111

Drug Class

Human

Market Date

Jul 15, 2016

Company
HC

sun pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02452111
AIG Number0149485002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BE08 TADALAFIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:12.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

TADALAFILActive
Strength: 20 MG
Monograph: TADALAFIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.